FDA: Protective Barrier Enclosures without Negative Pressure Increase Risks to COVID-19 Patients, Providers

August 26, 2020 | Risk Management News

Preview

What's the news. The U.S. Food and Drug Administration (FDA) has announced that the use of passive protective barrier enclosures without negative pressure when treating patients who are known or suspected to have coronavirus disease (COVID-19) may increase health risks to both patients and providers.

Access Full Content

Contact us today at 610.825.6000.